Product Description
Matriks Biotek Shikari® Shikari® (S-AIR) - Infliximab (Remsima®) (Antibody screening - Total semiquantitative) ELISA Kit
Enzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to infliximab biosimilar (Remsima®) in serum and plasma
This kit is a sandwich assay for the determination of total and free antibodies against infliximab in serum and plasma samples. This kit can be also used as a semi-quantitative test for free anti-drug antibodies determination without dissociation and neutralization steps.
Specifications:
| Required Volume (µl) | 40 |
| Total Time (min) | 95 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 156 |
| Spike Recovery (%) | - |
| Shelf Life (months) | 12 |
Standard Lead time : 3-4 Weeks (subject to change)
Documentation
Download sample IFU
Download sample MSDS
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
| Questions about this product? Ready to place an order? Email us at orders@iwai-chem.com or give us a call: (650) 486-1541 |
